Liposomal Drug Delivery: Three Decades from the First Liposomal Drug Delivery Medicine in Clinical Use
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (31 October 2023) | Viewed by 7659
Special Issue Editors
Interests: drug delivery systems; liposomes; polymers; nanotechnology; fractals
Special Issues, Collections and Topics in MDPI journals
Interests: synthesis of amphiphilic block copolymers and polyelectrolytes by controlled polymerizations; macromolecular assemblies; hybrid polymer-based nanostructures; nanomedicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liposomes are the first nanomedicines approved three decades back. From then to today, liposomal drug delivery have consistently played a central role in nanomedicine. Liposomal drugs are marketed medicines with great potential in the field of cancer therapy as well as other chronic and infectious diseases. Liposomes are vesicular systems composed of phospholipid bilayers, and their size ranges from a few tens of nanometers up to 1000 nanometers. They are biocompatible and biodegradable delivery nanosystems. Stealth liposomes are a sub-category of liposomes with biocompatible and low protein binding polymer coatings exhibiting a higher circulation time in the human blood, avoiding decomposition from plasma proteins. The quality by design and scale-up of liposomal formulations have attracted the interest of both the academic and industrial community.
This Special Issue is concerned with the applications of liposomes in physical chemistry, biology, pharmaceutical technology, and medicine. Topics may include physicochemical studies, self-assembly behavior, interactions of lipids/liposomes with active pharmaceutical ingredients and/or other excipients, the impact of liposomes on the drug release mechanism, as well as the utilization of liposomes as models of cellular membranes. The formation, preparation, and drug loading/release of lipid-based nanocarriers, liposomes, and hybrid liposomal carriers (combination with other nanomaterials) are hot topics in the current literature. Special attention will be given to applications of liposomes in the delivery of proteins/nucleic acids, in vaccinology, and immunology of cancer. Both original manuscripts and reviews are welcome.
Dr. Natassa Pippa
Dr. Asterios (Stergios) Pispas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- lipids
- drug delivery
- controlled release
- protein delivery
- vaccines
- cancer immunotherapy
- transdermal delivery
- lipid-based nanoparticles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.